Keeping up with type 1 diabetes technology changes in primary care ...

The indication is for patients 12 years and older hemophilia A with factor VIII inhibitors or hemophilia B with factor IX inhibitors. The FDA has approved concizumab-mtci (Alhemo; Novo Nordisk) in ...

The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up. The US Food and Drug Administration (FDA) has ...

Keeping up with type 1 diabetes technology changes in primary care ...

Keeping up with type 1 diabetes technology changes in primary care ...

Keeping up with type 1 diabetes technology changes in primary care ...

Keeping up with type 1 diabetes technology changes in primary care ...

Nathan Kuppermann, MD, MPH, explains the different quartiles of the pediatric emergency department readiness scale, and why the top tier is so crucial for pediatric patients. Nathan Kuppermann, MD, ...

Positive phase 3 data for inhaled insulin Afrezza Inhalation Powder (MannKind Corporation) in children and adolescents aged 4 to 17 years has been announced by MannKind Corporation. 1 According to the ...

"Tapinarof comes in with that mixture of the short-term studies and longer-term studies intermittently, giving us a nice, effective alternative non-steroid for eczema across the ages." Lawrence ...

This week, our experts weigh in on treatments not specifically indicated for COVID-19 treatment, including metformin, and concerns around using medications in this way. During the earliest stages of ...

"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ...